Global Investor Forum Contact

Kees Been

CEO, Lysosomal Therapeutics Inc.


18:30 - 21:00
Keynote VIP CEO-Investor Dinner

Kees is CEO of Lysosomal Therapeutics Inc (LTI), a biotech company focused on probing the lysosomal enzyme system for new drug targets in neurodegenerative diseases. Specifically, it is leveraging the genetic link between Gaucher’s and Parkinson’s disease (PD) to develop compounds that enhance the lysosomal glucocerebrosidase enzyme activity as an entirely new and breakthrough class of agents for the personalized and disease-modifying treatment in PD. The company is currently working toward an exit as part of its option-to-buy collaboration with Allergan. He was formerly CEO of EnVivo Pharmaceuticals (changed to FORUM Pharmaceuticals) for eight years working on cognition drugs for Alzheimer's and schizophrenia. He spent four years at Biogen, where he directed the Oncology Business Unit which was sold to Idec, and was head of Business Development.
Kees holds an MBA degree from INSEAD in France and graduated from the University of Agriculture in Holland, majoring in Molecular Biology and Process Engineering. Kees likes to spend his weekend mornings flying his single-engine airplane, exploring local airports in the New England area that offer brunch menus


Lysosomal Therapeutics, a journey of discovery

Kees Been
Lysosomal Therapeutics Inc.

Erik van de Berg

René Bernards
Qameleon Therapeutics & NKI

Annelien Bredenoord
UMC Utrecht

Carine van den Brink
AXON Lawyers

Danielle Curfs
Chemelot InSciTe
Jenny Dankelman
TU Delft
Diederik Dippel
Erasmus MC

Cornelia van Duijn
Erasmus MC

Lude Franke
Thibault Helleputte
Mark van Houdenhoven
St. Maartenskliniek
Henk Joos
Flanders Bio
Peter de Keizer
Erasmus MC
Tim Knotnerus
AM-Pharma, PRIMER Professionals
Angus Livingstone
Oncode Institute
Travis McCready
Massachusetts Life Sciences Center

Mirjam Mol
Pivot Park

Barend Mons
Timothy Noël
Eindhoven University of Technology
Jacquelien Noordhoek
Dutch CF Foundation
Violet Petit-Steeghs
Athena Institute
Thomas Plochg
Dirk Jan van der Pol
Anne Portwich
Elisabeth van Rossum
Erasmus MC
André van de Sande
Marlies Schijven
Hans Schikan
Topsector LSH
Hanneke Schuitemaker
Janssen Vaccines
Frits Schut
V.O. Patents & Trademarks
Marieke Schuurmans
UMC Utrecht
Jacob Seidell
Agaath Sluijter
Medical Delta
Thijs Spigt
Erasmus MC
Marianne van der Steen
Maastricht University
Maarten Steinbuch
Eindhoven University of Technology
Onno van de Stolpe
Werner Verbiest
Janssen Diagnostics
Martine de Vries

Edward van Wezel
BioGeneration Ventures

Jan van de Winkel

Loek Winter
DC Klinieken

Hanneke Heeres
Caroline Duterloo
Medical Delta
Paul Korte
Sponsors & Partners
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Platinum sponsor
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Award sponsor
Award sponsor
© 2017 Innovation for Health